content

Less Prostate Cancer Testing Leads To More Advanced Tumours

According to data from the U.S. Department of Veterans Affairs (VA), a reduction in prostate cancer screening has been associated with a subsequent rise...

Foundational partnership with Paradigm4 enables Alnylam Pharmaceuticals to rapidly accelerate RNAi- based drug target discovery

Paradigm4โ€™s REVEAL Integrative Analytics platform enables Alnylam Pharmaceuticals to discover novel, genetically-validated drug targets from population scale biobank genotype-phenotype datasets and underlies the extraordinary...

Transforming the clinical data management process with Agile

Introduction The clinical research industry wants to achieve the common goal of accelerating drug development by improving the process of data collection, data validation, analysis,...

Recipharm bolsters blow fill seal capabilities with Lab+

Global contract development and manufacturing organisation (CDMO) Recipharm, has bolstered its sterile filling capabilities by investing in Lab+ technology for low volume blow-fill-seal (BFS)...

Terumo Pharmaceutical Solutions offers next generation answer for challenging biotech drugs

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and a leading manufacturer of primary container, injection and infusion therapy devices, has launched a...

Scientists At ICR Research Cancer Response To New Treatments

Researchers discovered that by turning off the function of two genes, stomach tumours can become resistant to ATR inhibitors. As a result, genetic screening...

Epilepsy Patients To Receive Brain Laser Therapy From NHS

The NHS has made public its intentions to provide an avant-garde laser therapy for patients with epilepsy who have not previously responded well to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read